The Latest Ophthalmology Industry Statistics Explained
The global ophthalmology industry is expected to reach $55.17 billion by 2027, growing at a CAGR of 3.8%.
This statistic indicates that the global ophthalmology industry is projected to expand significantly, with an expected market value of $55.17 billion by the year 2027. This growth is anticipated to occur at a compound annual growth rate (CAGR) of 3.8%, demonstrating a steady and positive upward trend in the industry. Factors contributing to this growth may include advancements in technology, an aging population driving demand for eye care services, and increased access to healthcare services in emerging markets. Overall, the projected increase in market size suggests a promising future for the ophthalmology industry, with opportunities for innovation and investment in the coming years.
The Asia-Pacific region dominated the industry in 2020, and is expected to maintain its dominant position throughout the forecast period.
The statistic suggests that the Asia-Pacific region had a significant influence on the industry in 2020, taking the lead in terms of market share, revenue generation, or other industry-related metrics. This dominance is projected to continue over the forecast period, indicating that the region is likely to maintain its strong position and possibly further grow its impact within the industry. Factors such as economic growth, technological advancements, market demand, or favorable regulatory environments could be contributing to the region’s dominance and are expected to support its continuing influence in the future.
The global ophthalmic laser market size was $1,245 million in 2018, and is projected to reach $1443 million by 2026.
The statistic highlights the global market size of ophthalmic lasers in 2018, which was estimated to be $1,245 million. The projection indicates that the market is expected to grow to $1,443 million by the year 2026. This implies a potential increase in market value over the specified eight-year period. Factors contributing to this growth could include advancements in technology, an increasing prevalence of eye disorders, growing awareness about eye care, and the rising adoption of laser-based treatment options in ophthalmology. The statistic serves as a valuable insight into the anticipated growth and potential opportunities within the ophthalmic laser market in the coming years.
The rising prevalence of ocular diseases globally is a key factor that is predicted to boost the growth of the ophthalmology drugs and devices market size over the forecast period.
The statistic suggests that the increasing occurrence of ocular diseases on a global scale is expected to play a significant role in driving the growth of the market for ophthalmology drugs and devices in the coming years. This rise in prevalence indicates a growing demand for treatments and technologies to address these eye-related conditions, leading to the expansion of the market size. As a result, pharmaceutical companies and medical device manufacturers within the ophthalmology sector are likely to experience opportunities for innovation, development, and market penetration to meet the escalating needs of patients with ocular diseases.
North America prevailed as the most dominant region in the global ophthalmic drug market in 2020 accounting for 38.9% of total revenue.
The statistic that North America prevailed as the most dominant region in the global ophthalmic drug market in 2020, accounting for 38.9% of total revenue indicates that North America generated the highest revenue share within the ophthalmic drug market compared to other regions worldwide. This suggests that ophthalmic drug sales were most significant in North America in 2020. Factors such as advanced healthcare infrastructure, high prevalence of eye disorders and diseases, strong regulatory framework, and a large market of pharmaceutical companies likely contributed to North America’s dominance in the global ophthalmic drug market. Understanding this statistic can help pharmaceutical companies, policymakers, and healthcare professionals make informed decisions regarding product development, marketing strategies, and healthcare resource allocation for the ophthalmic sector in North America and globally.
The surgical procedure segment is expected to account for the largest share of the ophthalmology devices market.
This statistic suggests that the surgical procedure segment is projected to represent the largest portion of the ophthalmology devices market in terms of market share. This indicates that investments, sales, and overall economic value within the ophthalmology devices market are expected to be predominantly driven by products related to surgical procedures for eye conditions. The prominence of this segment could be attributed to factors such as technological advancements in surgical devices, increasing prevalence of eye disorders necessitating surgical interventions, and growing demand for innovative surgical solutions in the field of ophthalmology. As a result, businesses and stakeholders operating in the ophthalmology devices market may focus on developing and promoting surgical devices to capitalize on this substantial market share.
Market players are focusing on the development of advanced ophthalmology devices to strengthen their product portfolios and maintain their leadership in the market.
The statistic provided indicates that companies operating in the ophthalmology devices market are actively working on advancing their product offerings to gain a competitive edge and retain their market leadership positions. By focusing on developing advanced ophthalmology devices, these market players aim to enhance their product portfolios, which can help attract customers, drive sales, and differentiate themselves from competitors. This strategic approach enables companies to keep up with technological advancements, meet evolving customer needs, and ultimately, maintain their dominance in the market by offering innovative and high-quality solutions for various ophthalmic conditions and treatments.
Diabetic eye diseases cases expected to reach 191 million globally by 2030.
The statistic that diabetic eye diseases cases are expected to reach 191 million globally by 2030 highlights a significant increase in the prevalence of eye complications related to diabetes. As diabetes continues to be a growing health concern worldwide, the impact on eye health is becoming increasingly apparent. Vision-threatening complications such as diabetic retinopathy and diabetic macular edema are known to be major causes of visual impairment and blindness among individuals with diabetes. The projected figure serves as a stark reminder of the importance of early detection, proper management of diabetes, and regular eye screenings to prevent or delay the onset of these serious eye diseases.
Dry Eye Disease affects approximately 16 million adults in the U.S.
The statistic ‘Dry Eye Disease affects approximately 16 million adults in the U.S.’ indicates that a significant portion of the adult population in the United States experiences this chronic condition characterized by a lack of sufficient moisture and lubrication on the surface of the eye. This statistic underscores the prevalence and public health significance of Dry Eye Disease as a common ocular condition that can cause symptoms such as discomfort, irritation, blurred vision, and in severe cases, damage to the cornea and vision loss. The high number of affected individuals suggests a need for improved awareness, diagnosis, and management of Dry Eye Disease to enhance the quality of life and visual health for those experiencing this condition.
The global ophthalmic surgical instruments market size was estimated at USD 8.36 billion in 2017.
The statistic indicating that the global ophthalmic surgical instruments market was estimated to be valued at USD 8.36 billion in 2017 represents the total monetary worth of the market for instruments used in eye-related surgical procedures on a global scale for that particular year. This figure reflects the significant demand for ophthalmic surgical instruments due to factors such as a growing aging population, rising prevalence of eye disorders, and advancements in surgical technologies. The market size serves as a key indicator of the economic importance and growth potential of the ophthalmic surgical instruments industry, providing insights into the level of investment, research, and innovation within the sector.
The global ophthalmic therapeutics/drug market is anticipated to register a CAGR of 5.1% during the forecast period (2020 – 2025).
This statistic indicates that the global market for ophthalmic therapeutics and drugs is expected to experience a Compound Annual Growth Rate (CAGR) of 5.1% over the forecast period from 2020 to 2025. This means that the market size is projected to increase by an average of 5.1% each year during this period. The CAGR is a useful measure for understanding the steady growth rate of a market over time, providing insights into the growing demand and opportunities in the ophthalmic pharmaceutical industry. This forecast suggests that the market is expected to expand, likely driven by factors such as an aging population, increasing prevalence of eye disorders, technological advancements, and rising healthcare spending on eye care globally.
The global ophthalmic diagnostics market is estimated to be USD 3.6 billion in 2021 and expected to reach USD 4.6 billion by 2026, growing at a CAGR of 5.3%.
The statistic states that the global ophthalmic diagnostics market was valued at USD 3.6 billion in 2021 and is projected to increase to USD 4.6 billion by 2026, representing a Compound Annual Growth Rate (CAGR) of 5.3%. This signifies a positive trend in the market with a steady growth rate over the forecast period. The CAGR of 5.3% indicates that the market is expected to expand at a consistent pace, reflecting rising demand for ophthalmic diagnostic products and services worldwide. Factors such as increasing prevalence of eye disorders, advancements in technology, and growing emphasis on preventive healthcare are likely driving this growth in the global ophthalmic diagnostics market.
In 2020, the ophthalmic drug market in the United States was estimated at around 25.5 billion U.S. dollars.
The statistic states that the ophthalmic drug market in the United States reached an estimated value of approximately 25.5 billion U.S. dollars in the year 2020. This figure represents the total market size for pharmaceutical products used for eye-related conditions, including treatments for diseases such as glaucoma, dry eye, and age-related macular degeneration. The significant market size indicates a strong demand for ophthalmic drugs within the United States, driven by factors such as an aging population, increasing prevalence of eye disorders, and advancements in medical technology. The statistic highlights the economic importance of the ophthalmic drug industry and its contribution to the healthcare sector in the country.
The US has the highest number of ophthalmologists with 18,380, followed by Brazil with 7,360 and Japan with 7,257.
The statistic provided indicates the number of ophthalmologists in three countries – the US, Brazil, and Japan. The United States leads with the highest number of ophthalmologists at 18,380, followed by Brazil with 7,360 and Japan with 7,257. This data highlights the significant disparity in the number of ophthalmologists among these countries, with the US having substantially more eye care specialists compared to Brazil and Japan. The higher number of ophthalmologists in the US could potentially indicate better access to eye care services for its population compared to Brazil and Japan, where there are fewer practitioners per capita. This statistic underscores the importance of healthcare workforce distribution and access to specialized medical professionals like ophthalmologists in different countries.
Post-COVID-19, the market size for global tele-ophthalmology is projected to reach $6.2 billion by 2026 from $2.2 billion in 2021, at a CAGR of 23.2%.
This statistic indicates the projected growth in the market size for global tele-ophthalmology in the post-COVID-19 period. The market valuation is expected to increase from $2.2 billion in 2021 to $6.2 billion by 2026, representing a compound annual growth rate (CAGR) of 23.2%. This substantial growth is likely driven by increased adoption of telemedicine solutions due to the COVID-19 pandemic, which has accelerated the shift towards remote healthcare services. Tele-ophthalmology, which involves the remote diagnosis and treatment of eye-related conditions through telecommunication technologies, is expected to play a significant role in improving access to eye care services globally, driving the market expansion over the forecast period.
References
0. – https://www.www.mordorintelligence.com
1. – https://www.www.statista.com
2. – https://www.www.prnewswire.com
3. – https://www.www.mpo-mag.com
4. – https://www.www.healio.com
5. – https://www.www.alliedmarketresearch.com
6. – https://www.www.grandviewresearch.com
7. – https://www.www.fortunebusinessinsights.com
